American Pharmacists Association (APhA)
FDANonrulemakingFDA-2016-D-1270

Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases

RIN
Last modified
Apr 17, 2018
Comment window
closed 3582d ago
American Pharmacists Association (APhA) filings
1

Activity

American Pharmacists Association (APhA) filed 1 comment on this docket between Oct 12, 2016 and Oct 12, 2016. 13 other organizations filed here. The comment window closed 3582d ago.

What American Pharmacists Association (APhA) filed (1)

Oct 12, 2016· Comment from American Pharmacists Association· FDA-2016-D-1270-0023

Filed on regulations.gov — full text not in the inline record.

Abstract

No abstract recorded.

View on regulations.gov →
Use of Standards in FDA Regulatory Oversight of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Used for Diagnosing Germline Diseases (FDA) — American Pharmacists Association (APhA) | OpenPolis